Active Ingredient: DAPSONE
Proprietary Name: DAPSONE
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 7.5%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212701
Product Number: 001
Approval Date: May 31, 2023
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information